Scarica l'app Stockscreener
170.02
1.23%
1.96
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché KRYS Giù?
Forum
Previsione
Precedente Chiudi:
$168.06
Aprire:
$169.49
Volume 24 ore:
9,566
Relative Volume:
0.03
Capitalizzazione di mercato:
$4.68B
Reddito:
$290.51M
Utile/perdita netta:
$89.16M
Rapporto P/E:
56.86
EPS:
2.99
Flusso di cassa netto:
$119.18M
1 W Prestazione:
+5.07%
1M Prestazione:
-7.50%
6M Prestazione:
-3.83%
1 anno Prestazione:
+8.44%
Intervallo 1D:
$168.17
$171.84
Intervallo di 1 settimana:
$163.05
$176.73
Portata 52W:
$141.72
$219.34
Krystal Biotech Inc Stock (KRYS) Company Profile
Nome
Krystal Biotech Inc
Settore
Industria
Telefono
(412) 586-5830
Indirizzo
2100 WHARTON STREET, PITTSBURGH, PA
Confronta KRYS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
170.13 | 4.68B | 290.51M | 89.16M | 119.18M | 2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
496.72 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.03 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
621.30 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
255.27 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
250.95 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-05 | Iniziato | Jefferies | Buy |
| 2024-08-06 | Downgrade | Citigroup | Buy → Neutral |
| 2023-11-20 | Iniziato | Goldman | Buy |
| 2023-10-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-10-12 | Iniziato | Citigroup | Buy |
| 2023-09-07 | Iniziato | Berenberg | Buy |
| 2023-04-18 | Iniziato | Stifel | Buy |
| 2023-02-28 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-08-25 | Downgrade | Goldman | Buy → Neutral |
| 2022-01-18 | Iniziato | BofA Securities | Buy |
| 2021-07-20 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-09-18 | Iniziato | B. Riley FBR | Buy |
| 2020-06-04 | Iniziato | Evercore ISI | Outperform |
| 2019-09-24 | Iniziato | Goldman | Neutral |
| 2019-08-06 | Reiterato | H.C. Wainwright | Buy |
| 2019-06-24 | Reiterato | Chardan Capital Markets | Buy |
| 2019-06-24 | Reiterato | H.C. Wainwright | Buy |
| 2019-05-30 | Iniziato | Guggenheim | Buy |
| 2018-09-11 | Iniziato | Cantor Fitzgerald | Overweight |
Mostra tutto
Krystal Biotech Inc Borsa (KRYS) Ultime notizie
Krystal Biotech Gains EU Approval for VYJUVEK® - TipRanks
Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa - GlobeNewswire Inc.
Envestnet Asset Management Inc. Has $1.82 Million Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Acquired by LPL Financial LLC - Defense World
Wells Fargo & Company MN Boosts Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Pittsburgh biotech firms benefit in potential pharma tariffs and domestic manufacturing shift - The Business Journals
Krystal Biotech, Inc. to Present Innovative Genetic Medicine Programs at Upcoming Scientific Conferences - Nasdaq
Krystal Biotech to Present at Upcoming Scientific Conferences - The Manila Times
IBD Rating Upgrades: Krystal Biotech Flashes Improved Relative Price Strength - MSN
Bank of Montreal Can Has $521,000 Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Top Growth Companies With High Insider Ownership In April 2025 - simplywall.st
Krystal Biotech to Report First Quarter 2025 Financial Results on May 6, 2025 - The Manila Times
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Bought by Alliancebernstein L.P. - Defense World
Wellington Management Group LLP Sells 976 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Krystal Biotech, Inc. (NASDAQ:KRYS) Receives Average Recommendation of “Buy” from Analysts - Defense World
Gene Therapy Market Top Players-Krystal Biotech, Inc., - openPR.com
JPMorgan Chase & Co. Buys 23,934 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Krystal Biotech Becomes Oversold (KRYS) - Nasdaq
Krystal Biotech subsidiary Jeune Aesthetics taps Botox veteran as new CEO - The Business Journals
Is Kiniksa Pharmaceuticals (KNSA) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Krystal gets positive EU regulatory opinion for Vyjuvek - MSN
Jeune Aesthetics names Marc Forth as new CEO By Investing.com - Investing.com India
Jeune Aesthetics names Marc Forth as new CEO - Investing.com Australia
Jeune Aesthetics Appoints Marc Forth As Chief Executive Officer - MarketScreener
Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer - GlobeNewswire
Aesthetic Medicine Powerhouse: BOTOX Veteran Takes Helm at Jeune Aesthetics - Stock Titan
5 Biotech Stocks Worth Adding Amid Global Uncertainty in 2025 - Zacks Investment Research
Krystal Biotech Q1 EPS Forecast Reduced by William Blair - Defense World
Krystal Biotech: Some Uncertainty, Some Value (NASDAQ:KRYS) - Seeking Alpha
Norges Bank Purchases New Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
William Blair Raises Earnings Estimates for Krystal Biotech - Defense World
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Sei Investments Co. - Defense World
Commonwealth Equity Services LLC Boosts Stake in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Commonwealth Equity Services LLC Purchases 190 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - The AM Reporter
(KRYS) Proactive Strategies - news.stocktradersdaily.com
Teacher Retirement System of Texas Purchases 1,369 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Bought by Teacher Retirement System of Texas - Defense World
US High Growth Tech Stocks With Promising Potential - Yahoo Finance
Krystal Biotech: Preparing To Chase Following Positive CHMP Opinion For VYJUVEK - Seeking Alpha
How To Trade (KRYS) - news.stocktradersdaily.com
3 High Growth Companies Insiders Are Betting On - simplywall.st
Krystal Biotech (KRYS) Up 3.3% Since Last Earnings Report: Can It Continue? - Yahoo
Analysts Set Krystal Biotech, Inc. (NASDAQ:KRYS) PT at $220.00 - Defense World
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
Raymond James Financial Inc. Takes $15.99 Million Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Is Krystal Biotech, Inc.'s (NASDAQ:KRYS) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - Simply Wall St
Here's Why Krystal Biotech, Inc. (KRYS) is a Strong Momentum Stock - Yahoo Finance
US Bancorp DE Grows Stake in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Krystal Biotech, Inc. (NASDAQ:KRYS) Position Increased by Charles Schwab Investment Management Inc. - Defense World
Krystal Biotech Inc Azioni (KRYS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):